SCHEMBL2460415

SCHEMBL2460415

COC(=O)Oc1cccc2c1-c1ccccc1C2=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.54
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
KDM4E B2RXH2 3/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MAPT P10636 4/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
MAOA P21397 1/20 0.51
FGFR1 P11362 1/20 0.49
SRC P12931 1/20 0.49
FGFR2 P21802 1/20 0.49
FGFR4 P22455 1/20 0.49
FGFR3 P22607 1/20 0.49
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALDH1A1 P00352 2/20 0.49
USP2 O75604 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28341314 0.93 ELANE (0.57) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL6036890 0.83 ALDH1A1 (0.51) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL31435387 0.82 MAPT (0.70) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL11039554 0.81 ELANE (0.55) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL6220950 0.81 KEAP1 (0.49) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL6254697 0.80 KDM4E (0.63) MEN1KMT2AKDM4EHPGDHSD17B10
SCHEMBL8777904 0.80 ADORA2A (0.60) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL11102131 0.80 ELANE (0.53) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL7550657 0.79 CES1 (0.46) ELANEMEN1KMT2AKDM4EHPGD
SCHEMBL9279787 0.79 TTR (0.77) ELANEMEN1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035419-B1 5-ARYL-SUBSTITUTED DIHYDROPYRIDOPYRIMIDINES AND DIHYDROPYRIDAZINES AND USE THEREOF AS MINERAL CORTICOID ANTAGONISTS BAYER IP GMBH (DE) 2016-06-22 EP disclosed
EP-2029591-B1 SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINES AND USE THEREOF Bayer Pharma AG (DE) 2011-09-07 EP disclosed
EP-2035419-A1 5-ARYL-SUBSTITUTED DIHYDROPYRIDOPYRIMIDINES AND DIHYDROPYRIDAZINES AND USE THEREOF AS MINERAL CORTICOID ANTAGONISTS Bayer HealthCare AG (DE) 2009-03-18 EP disclosed
EP-2029591-A1 SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINES AND USE THEREOF Bayer HealthCare AG (DE) 2009-03-04 EP disclosed
WO-2007140934-A1 SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINES AND USE THEREOF BAYER HEALTHCARE AG (DE) 2007-12-13 WO disclosed
WO-2007140894-A1 5-ARYL-SUBSTITUTED DIHYDROPYRIDOPYRIMIDINES AND DIHYDROPYRIDAZINES AND USE THEREOF AS MINERAL CORTICOID ANTAGONISTS BAYER HEALTHCARE AG (DE) 2007-12-13 WO disclosed
WO-2005087740-A1 FLUORENONE 1, 4,-DIHYDROPYRIDIN DERIVATIVES BAYER HEALTHCARE AG (DE) 2005-09-22 WO disclosed